1. No category

Combined Dermatology Enrollment Form
Fax Referral To:
Phone:
Fax Referral To: 800-323-2445
Email
Referral
To:
Email Referral To: customerservicefax@caremark.com
Phone: 800-237-2767
6 Simple steps to submitting a referral
u PATIENT INFORMATION
v PRESCRIPTION INFORMATION
(Complete the following or include demographic sheet)
Patient Name:
Address:
City, State, Zip:
Primary Phone:
Home
Cell
Work
Alternate Phone:
Home
Cell
Work
DOB:
Gender:
Male Female
E-mail:
Last Four of SS #:
Primary Language:
Prescriber’s Name:
State License #:
DEA #:
Group or Hospital:
Address:
City, State, Zip:
Phone:
Contact Person:
w INSURANCE INFORMATION
NPI#:
Fax:
Phone:
Please fax copy of prescription and insurance cards with this form, if available (front and back)
x DIAGNOSIS AND CLINICAL INFORMATION
Diagnosis (ICD-9 or ICD-10)
696.1 Psoriasis
Other:
ICD-10 Code & Description:
Height:
y
696.0 Psoriatic Arthritis
In/cm
Weight:
172 Malignant Melanoma
kg/lbs
173 Basal Cell Carcinoma
Allergies:
PRESCRIPTION INFORMATION
MEDICATION
Enbrel®
Erivedge™
Humira®
DOSE/STRENGTH
50mg/ml Sureclick™ Autoinjector
50mg/ml Prefilled Syringe
25mg/0.5ml Prefilled Syringe
25mg Vial
150mg
DIRECTIONS
REFILLS
1
0
1
0
1 tablet by mouth once daily #30
Psoriasis Starter Package
Psoriasis Induction Dose: Inject two 40mg pens/syringes SC on day 1, then one 40mg pen/syringe
on day 8, then one 40mg pen every other week.
40mg/0.8ml Pen
40mg/0.8ml Prefilled Syringe
Psoriasis Maintenance Dose: Inject one 40mg pens/syringes SC every other week.
Psoriasis Arthritis Dose: Inject one 40 mg pen/syringe SC every other week.
Other:_________________________________________________________________________
Titration Starter Pack Rx
Take as directed x14 days #27 tablets, 0 refills
Otezla®
QUANTITY
Psoriasis Induction Dose: Inject 50mg SC TWICE a week (3-4 days apart) for 3 months, then
maintenance dosing.
Psoriasis Maintenance Dose: Inject 50mg SC ONCE a week.
Psoriatic Arthritis Dose: Inject 50mg SC ONCE a week.
Other:_________________________________________________________________________
Maintenance dose 30mg tablet orally twice daily
30 MG Tablet
Other:_________________________________________________________________________
Induction Dose: Infuse 5mg/kg in 250mL of 0.9% NaCl at week 0, week 2, week 6, and every 8
weeks thereafter.
Remicade®
100mg Vial
Maintenance Dose: Infuse 5mg/kg in 250ml of 0.9% NaCl every 8 weeks.
Other:_________________________________________________________________________
Simponi™
50mg/0.5ml SmartJect™
Autoinjector
50mg/0.5ml Prefilled Syringe
Stelara™
45mg/0.5ml prefilled syringe
90mg/mL prefilled syringe
Zelboraf®
240mg
Patient is interested in patient support programs
Psoriatic Arthritis Dose: Inject 50mg (0.5ml) subcutaneously once a month
Other:_________________________________________________________________________
For patients weighing < 100kg (220lbs): Inject 45mg SC initially and 4 weeks later, followed by
45mg every 12 weeks.
For patients weighing > 100kg (220lbs): Inject 90mg SC initially and 4 weeks later, followed by
90mg every 12 weeks.
4 tablets by mouth twice daily #240
STAMP SIGNATURE NOT ALLOWED
z x___________________________________
DISPENSE AS WRITTEN
(Date)
Ancillary supplies and kits provided as needed for administration
x___________________________________
PRODUCT SUBSTITUTION PERMITTED
(Date)
IMPORTANT
NOTICE: This
facsimile
transmission
is intended toisbe
delivered
to the named
andaddressee
may contain
material
that is material
confidential,
proprietary
or exampt
from disclosure
applicable law.
it is received
by Ifanyone
IMPORTANT
NOTICE:
This
facsimile transmission
intended
to only
be delivered
only addressee
to the named
and
may contain
thatprivileged,
is confidential,
privileged,
proprietary
or exemptunder
from disclosure
underIf applicable
law.
it is other than the named
addressee, the
recipient
should immediately
notify
the sender
at thethe
address
andshould
telephone
number set
forththe
herein
andatobtain
instructions
as to disposal
of theset
transmitted
material.
In noinstructions
even shouldassuch
materialof
bethe
read
or retainedmaterial.
by anyone
other
than the named
received
by anyone
other than the
named
addressee,
recipient
immediately
notify
sender
the address
and telephone
number
forth herein
and obtain
to disposal
transmitted
In no
event
addressee, except by express authority of the sender to the named addressee. Dermatology 031014
should such material be read or retained by anyone other than the named addressee, except by express authority of the sender to the named addressee. Hepatitis C 022514